ALPINE IMMUNE SCIENCES INC (ALPN) Forecast, Price Target & Analyst Ratings

NASDAQ:ALPN • US02083G1004

Current stock price

64.97 USD
+0.01 (+0.02%)
At close:
64.99 USD
+0.02 (+0.03%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALPINE IMMUNE SCIENCES INC (ALPN).

Forecast Snapshot

Consensus Price Target

Price Target
$62.73
-3.45% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 12, 2024
Period
Q2 / 2024
EPS Estimate
-$0.41
Revenue Estimate
3.559M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$62.73
Upside
-3.45%
From current price of $64.97 to mean target of $62.73, Based on 15 analyst forecasts
Low
$44.44
Median
$66.30
High
$68.25

Price Target Revisions

1 Month
-0.81%
3 Months
83.19%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for ALPN. The average price target is 62.73 USD. This implies a price decrease of -3.45% is expected in the next year compared to the current price of 64.97.
The average price target has been revised upward by 83.19% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALPN Current Analyst RatingALPN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ALPN Historical Analyst RatingsALPN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
ALPN was analyzed by 15 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about ALPN.
In the last month the buy percentage fell by 11 points. So the trust of analysts is decreasing.
ALPN was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-05-16WedbushReiterate Neutral -> Neutral
2024-04-16TD CowenDowngrade Buy -> Hold
2024-04-12Leerink PartnersDowngrade Outperform -> Market Perform
2024-04-11Wolfe ResearchDowngrade Outperform -> Peer Perform
2024-04-11RBC CapitalDowngrade Outperform -> Sector Perform
2024-04-11WedbushDowngrade Outperform -> Neutral
2024-04-11Morgan StanleyDowngrade Overweight -> Equal-Weight
2024-04-09GuggenheimInitiate Buy
2024-03-21HC Wainwright & Co.Maintains Buy -> Buy
2024-03-19OppenheimerReiterate Outperform -> Outperform
2024-03-19WedbushReiterate Outperform -> Outperform
2024-03-19Morgan StanleyMaintains Overweight -> Overweight
2024-03-19HC Wainwright & Co.Maintains Buy -> Buy
2024-03-12RBC CapitalMaintains Outperform -> Outperform
2024-02-15Wolfe ResearchInitiate Outperform
2024-01-26WedbushMaintains Outperform -> Outperform
2023-12-22HC Wainwright & Co.Maintains Buy -> Buy
2023-11-15WedbushReiterate Outperform -> Outperform
2023-11-03RBC CapitalMaintains Outperform -> Outperform
2023-11-03WedbushMaintains Outperform -> Outperform
2023-11-03Morgan StanleyMaintains Overweight -> Overweight
2023-10-18BerenbergInitiate Buy
2023-10-05RBC CapitalInitiate Outperform
2023-09-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-11OppenheimerMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 12, 2024
Period
Q2 / 2024
EPS Estimate
-$0.41
Revenue Estimate
3.559M
Revenue Q2Q
-58.58%
EPS Q2Q
-52.53%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-35.09%
EPS (1 Month)
3.87%
EPS (3 Months)
-9.12%

Next Earnings Summary

ALPN is expected to report earnings on 8/12/2024. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 3.56M USD.
The next earnings revenue estimate has been revised downward by 35.09% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ALPN revenue by date.ALPN revenue by date.
23.44M
150.96%		30.06M
28.24%		58.876M
95.86%		15.939M
-72.93%		16.653M
4.48%		10.132M
-39.16%		45.538M
349.45%		156.26M
243.14%		511.79M
227.52%		959.36M
87.45%		1.709B
78.14%
EBITDA
YoY % growth
ALPN ebitda by date.ALPN ebitda by date.
-49.24M
-74.80%		-57.55M
-16.88%		-43.674M
24.11%		-108.972M
-149.51%		-142.068M
-30.37%		-161.84M
-13.92%		-189.414M
-17.04%		-199.92M
-5.55%		N/AN/AN/A
EBIT
YoY % growth
ALPN ebit by date.ALPN ebit by date.
-49.86M
-73.43%		-58.15M
-16.63%		-44.25M
23.90%		-111.373M
-151.69%		-128.213M
-15.12%		-163.888M
-27.82%		-173.447M
-5.83%		-82.57M
52.39%		283.04M
442.79%		755.16M
166.80%		1.358B
79.83%
Operating Margin
ALPN operating margin by date.ALPN operating margin by date.
-212.71%-193.45%-75.16%-698.74%-769.91%-1,617.52%-380.88%-52.84%55.30%78.71%79.46%
EPS
YoY % growth
ALPN eps by date.ALPN eps by date.
-1.98
-43.48%		-1.68
15.15%		-0.67
60.12%		-1.73
-157.63%		-1.95
-12.70%		-2.48
-27.72%		-2.32
6.63%		-1.25
46.04%		2.91
332.52%		7.63
162.15%		15.18
98.90%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.41
-52.53%		-0.44
-82.96%		-0.40
-435.87%		-0.53
-89.43%		-0.54
-31.27%		-0.52
-18.47%		-0.53
-31.60%
Revenue
Q2Q % growth		3.559M
-58.58%		3.572M
-64.43%		5.328M
-82.73%
-100.00%
-100.00%
-100.00%
-100.00%
EBITDA
Q2Q % growth		-32.232M
-109.57%		-34.68M
-145.61%		-37.332M
-1,858.46%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-26.16M
-67.05%		-27.951M
-92.10%		-27.726M
-1,892.22%		-33.214M
-46.34%		-34.101M
-30.35%		-35.016M
-25.28%		-35.96M
-29.70%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALPN Yearly Revenue VS EstimatesALPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
ALPN Yearly EPS VS EstimatesALPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 5 -5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-54.78%
EPS Next 5 Year
-13.31%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-34.72%
Revenue Next 5 Year
33.81%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-35.27%
EBIT Next 5 Year
-25.05%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALPINE IMMUNE SCIENCES INC / ALPN Forecast FAQ

What is the price target for ALPN stock?

15 analysts have analysed ALPN and the average price target is 62.73 USD. This implies a price decrease of -3.45% is expected in the next year compared to the current price of 64.97.

What is the next earnings date for ALPN stock?

ALPINE IMMUNE SCIENCES INC (ALPN) will report earnings on 2024-08-12, after the market close.

Can you provide the consensus estimates for ALPINE IMMUNE SCIENCES INC next earnings?

The consensus EPS estimate for the next earnings of ALPINE IMMUNE SCIENCES INC (ALPN) is -0.41 USD and the consensus revenue estimate is 3.56M USD.

Can you provide the expected long term growth rate for ALPINE IMMUNE SCIENCES INC stock?

The expected long term growth rate for ALPINE IMMUNE SCIENCES INC (ALPN) is -34.72%.